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Abstract
Tryptamine was converted to the corresponding 1,2,4-triazole, 1,3,4-oxadiazole, 5-oxo-1,3-thia(oxa)
zolidine and 5-(4-chlorophenyl)-1,3-thia(oxa)zole derivatives via several steps. 1,3,4-oxadiazole and 
1,2,4-triazoles were then converted to the corresponding Mannich bases containing fl uroquinolone core 
using a one-pot three-components procedure. Conventional and microwave-assisted methods were applied 
for all syntheses. All the newly synthesized compounds were screened for their antibacterial and most of 
them were found to have good–moderate antibacterial activity.
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Introduction
The increasing community- and hospital- acquired 
infectious diseases caused by resistant bacteria to most classes 
of antibacterial drugs resulted in a pressing and urgent need 
for designing of new antibiotic candidates. The declaration 
of The European Centre for Disease Prevention and Control 
(ECDC) reporting “Every year, the infections caused by 
resistant bacteria gives rise to 25,000 deaths with a cost of over 
1.5 billion Euro because of healthcare spending and labor losses 
in the Europa” reveals that this is a public health problem with 
also socio-economic loses [1-5]. 
In recent years, to overcome the drug resistance problem, 
the concept of hybrid molecules, which contain two or more 
pharmacophore groups binding together covalently in one 
molecular framework, has been introduced in the medicinal 
chemistry fi eld. These compounds that are obtained by 
molecular hybridization of several pharmacophore groups, act 
by inhibiting two or more conventional targets simultaneously, 
and this multiple target strategy has resulted in the 
development of a number of bioactive hybrid molecules with 
desired pharmacokinetic profi le, therapeutic index and more 
importantly less tendency to resistance [6-11]. 
Heterocyclic compounds accepted as medicinally important 
products have given a new direction to new drug design 
and discovery studies. 1,2,4-Triazole, 1,3,4-oxadiazole and 
1,3-thiazole derivatives which attract great attention by 
synthetic and medicinal chemists due to their distinct structures 
have been regarded as useful tools for drug discovery processes 
[12-14]. The compounds containing these heterocyclic units 
in their structures have been reported to possess a wide range 
of biological activities, such as antibacterial, antitubercular, 
antiviral, analgesic, antioxidant, anticancer etc [15-18]. 
Another class of bioactive compounds, indoles exhibit several 
biological activities with high bioavailability and relatively 
low toxicity. Indole unit constitutes a part of several natural 
compounds isolated from marine creatures, medicinal plants 
or microorganisms. Although a number of studies devoted 
on the modifi cations of indole unit was reported, there 
are only a few studies about indole-azole hybrids. Based 
on the pharmacodynamic principle of superposition, it is 
accepted that the indole hybrids containing 1,3,4-oxadiazole 
and 1,2,4-triazole units at the position 3 exhibit effi cient 
antibacterial activity [19,20]. 
In the anti-infective chemotherapy fi eld, fl uoroquinolones 
which target two type II bacterial topoisomerase enzymes, 
DNA gyrase and/or topoisomerase IV, constitute a large and 
constantly expanding group of synthetic antibiotics. They have 
been attracting major interest due to broad-spectrum of activity 
towards both Gram (-) and Gram (+) bacteria by inhibiting 
bacterial DNA replication, and their chemotherapeutic effi cacy 
[8-11]. In the concept containing the synthesis of new analogs 
or modifying existing drug compounds, new fl uoroquinolones 
including large substituent at the position 7 were reported 
by several research groups [7,21-25]. Microwave assisted 
techniques were reported to be more effective in terms of 
011
Citation: Cebeci YU, Özdemir SB, Demirbas A, Demirbas 1N, Karaoglu SA (2018) Microwave Irradiated and Conventional Synthesis, Antibacterial Activity Evaluation 
Studies of Tryptamine-Azole-Fluoroquinolone Conjugates. Biomed Sci Eng 4(1): 010-020. DOI: http://dx.doi.org/10.17352/abse.000009
environment, reaction time, high yields, ease of work-up and 
isolation of products. Moreover, the environmentally polluting 
solvents with high boiling points which are often expensive, 
toxic, diffi cult to remove are not necessary most of the 
microwave assisted synthesis [26].
Recently, multicomponent reactions (MCRs) have received 
considerable attention by synthetic organic and medicinal 
chemists for the construction of complex molecules having 
biological activity. When compared with conventional organic 
reactions and maximal structural complexity MCRs have 
some superior properties including high conversion rate, 
minimal reaction time and structural complexity. Thus, 
MCRs are also considered as green chemical processes [27]. 
Among these, Mannich reaction, a one pot three-component 
condensation reaction, provide synthetically and biologically 
important β-aminoalkylated compounds, which are important 
intermediates for the construction of various nitrogen-
containing natural products and pharmaceuticals [28].
Thus, based on the aforementioned statements, this study 
focused on the design, ecofriendly synthesis, and antibacterial 
activity evaluation of new indole-azole-fl uoroquinolone 
hybrids based on pharmacophores hybridization. Indole 
scaffold was selected as the key prototype structural unit and 
the integration of indole skeleton, azole and fl uoroquinolone 
pharmacophores we attempted to conventional and MW 
mediated green synthesizes of new indole-azole hybrid 
scaffold in the one molecular frame was performed as shown 
in fi gure 1 with the aim to prepare new antibacterial agents 
with preferably therapeutic profi le having less tendency to 
antibacterial resistance.
Results and Discussion
Chemistry
In this study, we attempted to conventional and MW mediated 
green synthesize of new indole-azole-fl uoroquinolone hybrids 
as possible drug candidates with antibacterial activity. On the 
basis of 1H, 13C NMR, FT IR and EI-MS data, the structure of the 
target products was established. All synthesized compounds 
were checked for purity and identity using elemental analysis. 
The MICs against clinically important Gram-negative and Gram 
positive pathogens were determined as well. The synthetic 
methodologies adopted to obtain the target compounds were 
depicted in Scheme 1 and Scheme 2. 
The treatment of the starting compound, tryptamine 
[2-(1H-indol-3-yl)ethanamine], which was selected 
considering its biological importance [29-33], with ethyl 
bromoacetate to give ethyl 2-[2-(1H-indol-3-yl)ethylamino]
acetate (2) was carried out under conventional and also 
microwave (MW) irradiated conditions with a view to 
maximizing the yield of the product and minimizing the 
reaction time. With the assessing of MW irradiated method, 
the yield of the reaction was improved to good level (87 %) 
however, more signifi cantly, the reaction time for complete 
consumption of starting materials was lowered from 18 h with 
conventional stirring to a remarkable 10 min. Moreover, MW 
irradiated method with no solvent supplied more ecofriendly 
way. The structure compound 2 was confi rmed by the 
disappearance of broad singlet for NH2 and the presence of 
triplet at the region 1.90-1.93 ppm and a quartet at 2.85-2.89 
ppm due to the presence of ethyl group protons in the 1H NMR 
spectrum of compound 2. This group appeared at 14.68 ppm 
(CH3) and 61.18 ppm (CH2) in the 
13C NMR spectrum. Further, 
in the FT IR, the appearance of the stretching band due to 
C=O group at the region 1619 cm-1 confi rmed the formation Figure 1: 
Scheme 1: Reaction and conditions for the preparation of compounds 2-5. I 
BrCH2CO2Et, Rt3N, 24 hr rt or MW (180 W.), 10min; ii: H2NNH2, H2O, ref 15 he or MW 
(220 W) 6 min; iii: CS2. KOH, EtOH, ref, 8 h or MW (250 W) 10 min; iv: norfl oxacin or 
ciprofl oxacin, HCHO, InCI3, rt, 24 h or MW (100 W), InCI3. 7 min
Scheme 2: Synthetic pathway for the preparation of compounds 6-10. I: 
benzelisothiocyanate, phenyliso (thio)cyanate, DCM, rt, 24 h or MW (150 W), 8 min; 
ii: NaOH+H2O, ref. 6 h or MW (200 W), 18 min; iIi:  norfl oxacin or ciprofl oxacin, HCHO, 
InCI3,, DMH, rt 24 h or MW (100 W), InCI3,  7 min; iv: BrCH2CO2Et, NaOAc, EtOH, ref 18 
or MW (180 W), 17 min; v: BrCH2C6H4CI(4-), NaOAc, EtOH, ref, 17-20 h or MW (200 
W) 22 min
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of ester (2). The substitution of ester group by hydrazide 
generated 2-[2-(1H-indol-3-yl)ethylamino]acetohydrazide 
(3), which were confi rmed by the appearance of broad signal 
for -NHNH2 group in FT IR. Further, the protons of hydrazide 
function appeared at 3.93 (NH2) and 10.94 ppm (NH) as D2O 
exchangeable singlets confi rming the formation of hydrazide. 
In order to optimize microwave (MW) irradiation conditions, 
MW was applied at different power values of 120 and 150 W 
without any solvent, while the conventional synthesis of 
compound 3 required ethanol as reaction solvent. The complete 
conversion of the compound 2 in best yield was observed after 
microwave irradiation at 220 W maximum power for 6 min. 
Higher MW power or longer reaction time caused to lower 
yields. Compound 3 gave the corresponding 1,3,4-oxadiazole 
derivative (4) upon the treatment with carbon disulfi de in 
basic media. The 13C NMR observations revealed the appearance 
1,3,4-oxadiazole C-2 and C-5 carbons at the region 166.19 ppm 
and 163.99 ppm confi rming the formation of 1,3,4-oxadiazole 
[34, 35]. The stretching band characteristic for SH absorption 
was seen at 2921 cm-1 in the FT IR spectrum. The signal 
observed at 13.69 ppm in the 1H NMR spectrum was attributed 
the SH proton. On the other hand, the treatment of compound 
3 with alkyliso(thio)cyanates produced the corresponding 
hydrazincarbo(thio)amides (6a-c) with both conventional 
and MW irradiated method. In the conventional method, the 
reaction yielding compounds 6a-c completed in 24 h in DCM 
with 86-91 % yield, while reaction time was 8 min with the 
yield 97-99 %. The structures of hydrazinecarbo(thio)amides 
were confi rmed by the presence of additional signals at the 
related chemical shift values originated from alkyliso(thio)
cyanate moiety. This compound exhibited mass fragmental and 
elemental analysis data confi rming the assigned structures. 
The basic treatment of compounds 6a-c produced the 
corresponding 1,2,4-triazoles (7a-c), which can be considered 
as important tools for further condensation reactions leading 
to the formation of new bioactive molecules. The reaction was 
carried out in water-ethanol as a none toxic ecofriendly solvent 
mixture under refl ux and also microwave conditions. With the 
use of MW conditions, higher yields and lower reaction times 
were assessed. Microwave irradiation decreased the reaction 
time from 6 h to 18 min and increased the yields from 56-63 % 
to 93–97 %. The optimum reaction condition was assessed at 
200 W maximum power (Table 1).
The FT IR spectra of compounds 7a-c have -C=S or C=O 
and -NH stretching bands at 1223-1284 cm-1, 1683 cm-1 
and 3163-3397 cm-1, respectively. In the 1H NMR spectra, 
resonances assigned to the -NH proton on 1,2,4-triazole ring 
were detected at 10.34-11.40 ppm (NH) which are supported 
by the literature fi ndings [36-40]. 13C NMR spectra of these 
compounds have resonances of triazole C-5 and C-3 at 156.63-
181.79 ppm and 153.21-171.51 ppm, respectively. The one-
pot, three-component Mannich type reaction of compounds 
4 and 7a-c with norfl oxacin and ciprofl oxacin, which are 
fl uoroquinolone class antibiotics, yielded the indole-azole-
fl uoroquinolone hybrids as new drug candidates (5a,b and 
8a-f) with best antibacterial activity. This reaction proceeds 
via the formation of immonium salt which subsequently 
attacks the N-1 of triazole or oxadiazole N-3 giving rise to the 
corresponding Mannich bases. In the preliminary experiment, 
to optimize the conditions for this condensation, the synthesis 
of compound 8a was selected as model reaction and various 
reaction parameters including time, solvent and MW power 
were screened on the model reaction (Table 2). With the aim 
to provide further improvement for this synthetic approach, 
the model reaction was also performed in the presence of 
polar solvents including THF, H2O, EtOH, and DMF, however, 
the best result was assessed in solvent free media and the 
corresponding product was obtained in nearly quantitative 
yields within 10 min (Table 2, entry 10) in model reaction under 
microwave irradiation. Secondly, the effect of different catalyst 
on the reaction yield was screened (Table 2). For this purpose, 
several Bronsted and Lewis acids including p-TSA, FeCl3, InCl3, 
HCl were examined in the optimized reaction conditions (Table 
2, entry 10) and completion of the reaction was monitored 
by TLC. The screening studies exhibited that the character of 
solvent and catalyst has no important infl uence on the reaction 
yield. Even so, quite good yields with 83% were obtained with 
InCl3 (Table 2, entry 14). Furthermore, the TLC analysis showed 
that the duration of the reaction with catalyst was shorter 3 
minutes than the non-catalytic reaction (Table 2, entry 14). 
Table 1: Time, Power and yield data for compounds 2-4, 6a-c and 7a-c, 9a-cand 10a-c.
Comp.
Microwave irradiation Method Conventional method
time (min) Power (W) Yield (%) Time (h) Yield (%)
2 10 180 87 24 69
3 6 220 97 15 70
4 10 250 96 8 73
5a 7 100 90 24 70
5b 7 100 92 24 70
6a 8 150 99 24 91
6b 8 150 97 24 91
6c 8 150 99 24 86
7a 18 200 93 6 61
7b 18 200 95 6 63
7c 18 200 97 6 56
9a 17 180 71 18 63
9b 17 180 63 18 57
9c 17 180 66 18 48
10a 22 200 72 18 45
10b 22 200 75 17 51
10c 22 200 73 20 49
Table 2: Optimization of the model reaction conditions for compound 8a.
Entry Time(min)
Power
 (W)
Yield 
(%) Solvent
Catalyst
(10%)
1  20 200 66 THF -
2  15 150 54 THF -
3  20 150 75 EtOH -
4  15 200 53 EtOH -
5  10 100 42 H2O -
6  18 150 36 H2O -
7  10 100 63 DMF -
8  15 100 58 DMF -
9  15 120 75 - -
10  10 100 78 - -
11 8 100 79 - p-TSA
12 8 100 79 - FeCl3
13 7 100 80 - HCl
14 7 100 83 - InCl3
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In comparison with the long refl uxing time in hazardous 
solvent, microwave irradiation provided more effi cient 
and green way for one pot Mannich type condensation with 
relatively higher product yield. The number of signals and their 
chemical shifts are in accordance with the assigned structures 
for the Mannich bases. In the 1H and 13C NMR spectra, additional 
signals corresponding to norfl oxacin or ciprofl oxacin skeleton 
were recorded at the related chemical shift values, while the 
spectra of these compounds showed the disappearance of the 
characteristic bands of triazole (or oxadiazole)-NH. Moreover, 
the preparation of Mannich bases was verifi ed by registration 
of their mass spectrums which were in accordance with their 
molecular masses and the elemental analysis data (carbon, 
hydrogen and nitrogen) were ±0.4% of the theoretical values.
Until today, several methods have been developed for the 
preparation of 1,3-thiazoles, however, Hantzsch synthesis 
containing the reaction of β-halogenocarbonyl components 
with the compounds including a thioamide function is the 
procedure most often referred to. According to the accepted 
mechanism, the attack of sulfur atom of thioamide, which 
is present in its ene- thiole form to the halogen atom of 
carbonyl compound, and this attack is followed by HBr and H2O 
elimination, which leads to the 1,3thiazole ring formation [36].
As different from the classical Hantzsch reaction, the fact 
that hydrazinecarbo(thio)amides synthesized in the present 
study (6a-c) have more than one nucleophilic center and 
2-bromo-1-(4-chlorophenyl)ethanone, that is the carbonyl 
component in this reaction has two position for nucleophilic 
attacks, can cause the formation of different structural isomers; 
each of them can exist as their individual E and Z geometrical 
[3,4,37-40].
In our previous studies [37,38,40], to identify the 
exact structure of type of compounds 10a-c, full geometric 
optimization of the possible isomer products was obtained 
by DFT/B3LYP (density functional theory with B3LYP-the 
hybrid Becke’s three parameter functional and Lee–Yang–
Parr exchange–correlation potential) method with the 
6-31G (d,p) basis set and the structure of the molecules was 
also investigated in detail. According to the obtained results 
[37,38], the most stable product is Z geometrical isomer with 
the calculated relative energy 0.000 kcal mol-1. Therefore, 
thermodynamically, the formation of Z isomers is more 
favorable. Similar case is present for compounds 9a-c.
Antibacterial activity
All newly synthesized compounds were screened for their 
antibacterial activity and the results obtained were submitted 
in Table 3. Most of the compounds synthesized in the present 
study exhibited activity on the test microorganisms. Among 
them, 5a,b and 8a-f and which contain a fl uoroquinolone 
nucleus in their structures, demonstrated excellent activities 
on Gram positive and Gram negative bacteria of the test 
microorganisms with the mic values <0.24 μg/mL. Compound 
4, 6c and 7c demonstrated activity against Mycobacterium 
smegmatis(Ms), an atipical tuberculosis factor, with the mic 
values 62.5 μg/mL. No important activity was observed for 
the remaining compounds. According to the results presented 
in table 3, it can be concluded that the superior antibacterial 
activity of compounds 5a,b and 8a-f is due to the presence of 
fl uoroquinolone core in their structures.
Con clusion
This study reports the conventional and successfully de-
veloped microwave assisted synthesis of some new hybrid 
molecules containing several heterocyclic moieties having im-
portance for biological activity. Hence, we combined all these 
potential chemotherapeutic units, namely indole, 1,3,4-oxa-
diazole, 1,2,4-triazole, fl uoroquinolone and/or 1,3-thiazole 
moieties.
The structures of new compounds were confi rmed by IR, 1H-, 
13C NMR, mass spectroscopic and elemental analysis techniques. 
In addition, the newly synthesized compounds were screened 
for their antimicrobial activities. The antimicrobial screening 
suggests that the compounds containing fl uoroquinolone 
core exhibited excellent activities against most of the test 
microorganisms. 
Experimental Section
Chemistry
All the chemicals were purchased from Fluka Chemie AG 
Buchs (Switzerland) and used without further purifi cation. 
Melting points of the synthesized compounds were determined 
Tablo 3: Screening for antibacterial activity of the newly synthesized compounds.
Comp.
No
Microorganizms and Minimal Inhibitory Concentration (μg/mL)
Ec Yp Pa Sa Ef Bc Ms
              2  - - - 250 - -   -
3  250 - - - - - -
4  250 - - 250 - - 62.5
5a <0.24 <0.24 <0.24 <0.24 <0.24 <0.24 -
5b <0.24 <0.24 <0.24 <0.24 <0.24 <0.24 -
6a - - - - - - -
6b - - - - - - -
6c 250 - - - - - 62.5
7a  - - - - - - -
7b - - - - - - -
7c  - - - - - - 62.5
 8a <0.24 <0.24 <0.24 <0.24 <0.24 <0.24 <0.24
8b <0.24 <0.24 <0.24 <0.24 <0.24 <0.24 <0.24
8c <0.24 <0.24 <0.24 <0.24 <0.24 <0.24 <0.24
8d <0.24 <0.24 <0.24 <0.24 <0.24 <0.24 <0.24
8e <0.24 <0.24 <0.24 <0.24 <0.24 <0.24 <0.24
8f <0.24 <0.24 <0.24 <0.24 <0.24 <0.24 <0.24
9a 125 - 500 - - - -
9c - - - - - - -
10a 125 - 500 - - - -
10c 500 - 500 - - - -
Amp. 10 18 >128 10 35 15
Strep. 4
Norf. <0.24 <0.24 <0.24 <0.24 <0.24 <0.24 <0.24
Ec: Escherichia coli ATCC 25922, Yp: Yersinia pseudotuberculosis ATCC 911, 
Pa: Pseudomonas aeruginosa ATCC 43288, Sa: Staphylococcus aureus ATCC 
25923, Ef: Enterococcus faecalis ATCC 29212, Bc: Bacillus cereus 702 Roma, Ms: 
Mycobacterium smegmatis ATCC607, Saccharomyces cerevisiae RSKK 251, Amp: 
Ampicillin, Str.: Streptomycin, Norf.: Norfl oxacin, (—): no activity.
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in open capillaries on a Büchi B-540 melting point apparatus 
and are uncorrected. Reactions were monitored by thin-
layer chromatography(TLC) on silica gel 60 F254 aluminium 
sheets. The mobile phase was ethyl acetate/diethyl ether 1:1 
and detection was made using UV light. FT-IR spectra were 
recorded as potassium bromide pellets using a Perkin Elmer 
1600 series FTIR spectrometer. 1H NMR and 13C NMR spectra 
were registered in DMSO-d6 on a Bruker Avance II 400 MHz 
NMR spectrometer (400.13 MHz for 1H and 100.62 MHz for 13C). 
The chemical shifts are given in ppm relative to Me4Si as an 
internal reference; J values are given in Hz. All the compounds 
gave C, H, and N analyses within ±0.4% of the theoretical 
values. The mass spectra were obtained on a Quattro EI-MS (70 
eV) instrument. Physical parameters for synthetic procedures 
were given in table 1.
Ethyl 2-(2-(1H-indol-3-yl)ethylamino)acetate (2)
Met h od 1: To a solution of the corresponding compound 1 
(10 mmol) in tetrahydrofuran, triethylamine (20 mmol) and 
ethyl bromoacetate (10 mmol) were added and the mixture was 
stirred at room temperature for 24 hours. The precipitate was 
removed by fi ltration and the resulting solution was evaporated 
under reduced pressure to dryness. The crude product obtained 
was purifi ed by column chromatography (silica gel, hexane/
ethyl acetate 7:3).
Method 2: The mixture of ethyl bromoacetate (10 mmol), 
compound 1 (10 mmol) and triethylamine (20 mmol) was 
irradiated in monomod microwave reactor in closed vessel with 
pressure control (Table 1). The crude product obtained was 
purifi ed by column chromatography (silica gel, hexane/ethyl 
acetate 7:3).
FT-IR (υ max/cm-1): 3243 (NH), 1732 and 1619 (2C=O), 1117 
(C-O). 1H NMR (DMSO-d6, δ ppm): 1.90-1.93 (3H, m, CH3), 
2.85-2.89 (4H, m, 2CH2), 3.31 (2H, s, CH2), 3.51 (2H, s, CH2), 
6.96-7.09 (3H, m, arH), 7.37 (1H, d, J= 8.0 Hz, arH), 7.53 (1H, d, 
J= 8.0 Hz, CH), 10.85 (2H, s, 2NH). 13C NMR (DMSO-d6, δ ppm): 
14.68 (CH3), 45.48 (CH2), 52.14 (CH2), 61.18 (CH2), 69.90 (CH2), 
arC: [101.42 (CH), 104.99 (CH), 108.45 (CH), 121.10 (CH), 122.19 
(CH), 130.23 (C), 145.75 (C), 154.49 (C)], 172.11 (C=O).EI MS m/z 
(%): 130.80 (100), 195.88 (68), 152.83 (64), 196.89 (54), 124.80 
(43), 162.84 (42), 208.90 (38), 190.94 (37), 210.90 (23), 283.05 
([M+2+K]+, 19). 
2-(2-(1H-Indol-3-yl)ethylamino)acetohydrazide (3)
Met h od 1: A solution of compound 2 (10 mmol) in ethanol 
was refluxed with hydrazine hydrate (25 mmol) for 15 h. The 
crude product obtained was purifi ed by column chromatography 
(silica gel, hexane/ethyl acetate 7:3).
Method 2: The solution of compound 2 (10 mmol) in 
hydrazine hydrate (25 mmol) was irradiated in a monomod 
microwave reactor in closed vessel with the pressure control 
(Table 1). The crude product obtained was purifi ed by column 
chromatography (silica gel, hexane/ethyl acetate 7:3).
FT-IR (υ max, cm-1): 3259 (NH2+3NH), 3052 (aromatic CH), 
1666 (C=O). 1H NMR (DMSO-d6, δ ppm): 2.74 (2H, d, J= 4.0 Hz, 
CH2), 2.77-2.81 (2H, m, CH2), 3.13 (2H, s, CH2), 3.93 (2H, brs, 
NH2), 6.94-6.98 (1H, m, arH), 6.99-7.07 (1H, m, arH), 7.12-
7.33 (1H, m, arH ), 7.35 (1H, s, arH), 7.51 (1H, d, J= 8.0 Hz, CH), 
10.82 (2H, s, 2NH), 10.94 (1H, s, NH). 13C NMR (DMSO-d6, δ 
ppm): 50.03 (CH2-NH), 51.26 (CH2), 57.97 (CH2), 111.80 (CH), 
arC: [118.66 (CH), 118.76 (CH), 121.33 (CH), 123.01 (CH), 127.72 
(C), 136.70 (C), 169.85 (C)], 170.86 (C=O). EI MS m/z (%): 144.18 
(100), 233.29 ([M+1]+, 21), 117.27 (18), 145.31 (12). 
5-{[2-(1H-Indol-3-yl)ethylamino]methyl}-1,3,4-oxadia-
zole-2-thiol (4)
Met h od 1: CS2 (10 mmol) was added to the solution of 
compound 3 (10 mmol) in ethanol-water (1:1) and the mixture 
was refl uxed in the presence of KOH (10 mmol) for 8 h. Then, 
the resulting solution was cooled to room temperature and 
acidifi ed to pH 4 with 37% HCl. The solid precipitate was 
collected by fi ltration and recrystallized from methanol to give 
the pure compound.
Method 2: The mixture of compound 3 (10 mmol), CS2 (10 
mmol) and KOH (10 mmol) in ethanol-water (1:1) was irradiated 
in monomod microwave reactor in closed vessel with pressure 
control (Table 1). Then, the resulting solution was cooled to 
room temperature and acidifi ed to pH 4 with 37% HCl. This 
was collected by fi ltration and recrystallized from methanol to 
give the pure compound. FT-IR (υ max/cm-1): 3247 (NH), 2921 
(SH), 1456 (C=N). 1H NMR (DMSO-d6, δ  ppm): 1.07 (2H, s, CH2), 
3.15 (2H, s, CH2), 395 (2H, s, CH2), 6.99-7.06 (3H, m, arH), 
7.08-7.17 (1H, m, arH), 7.34 (1H, d, J=8.0 Hz, CH), 10.85 (1H, s, 
NH), 10.90 (1H, s, NH), 13.69 (1H, s, SH). 13C NMR (DMSO-d6, 
δ ppm): 45.32 (CH2), 46.42 (CH2), 50.27 (CH2), arC: [110.43 
(C), 112.03 (CH), 118.89 (CH), 121.57 (CH), 123.28 (CH), 123.62 
(CH), 12757 (C), 136.71 (C)], 163.99 (oxadiazole C-5), 166.19 
(oxadiazole C-2).EI MS m/z (%): 144.31 (100), 117.21 (34), 119.21 
(21), 145.31 (12). 
General Method for the Synthesis of Compounds 5a, 5b 
Method 1: To a solution of corresponding compound 4 
(10 mmol) in dimethyl formamide containing InCl3 (1 mmol), 
ciprofl oxacin or norfl oxacin (10 mmol) was added and the 
mixture was stirred at room temperature in the presence 
of formaldehyde (30 mmol) for 24 h. The solid precipitate 
was fi ltered off, washed with water and recrystallized from 
dimethyl sulfoxide:water (1:1) to give the desired compound.
Method 2: The mixture consisting of compound 4 (10 mmol), 
ciprofl oxacin or norfl oxacin, formaldehyde (30 mmol) and 
InCl3 (1 mmol) was irradiated in monomod microwave reactor 
in closed vessel with pressure control at 100 W maximum 
power for 7 min. The obtained solid was washed with water 
and recrystallized from dimethyl sulfoxide:water (1:1) to give 
the desired compound.
7-{4-[(5-[(2-(1H-Indol-3-yl)ethylamino)methyl]-2-
thioxo-1,3,4-oxadiazol-3(2H)-yl)methyl]piperazin-1-yl}-
1-cyclopropyl-6-fluoro-4-oxo-1,4-dihydroquinoline-3-
carboxylic acid (5a). M.p. 183-185 oC. FT-IR (υmax, cm-1): 3058 
(aromatic CH), 1717 (C=O), 1664 (C=O), 1225 (C=S). 1H NMR 
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(DMSO-d6, δ ppm): 1.13 (2H, s, CH2), 1.27 (2H, s, CH2), 2.73 (4H, 
s, 2CH2), 2.89 (4H, s, 2CH2), 3.27 (2H, s, CH2), 3.75 (2H, s, CH2), 
3.93 (2H, s, CH2), 4.96 (2H, s, CH2), 5.11 (1H, s, CH), 7.03-7.33 
(3H, m, arH), 7.45-7.95 (3H, m, arH), 8.61 (2H, s, 2CH), 11.05 
(2H, s, 2NH), 15.12 (1H, s, OH). 13C NMR (DMSO-d6, δ ppm): 
17.99 (2CH2), 40.61 (2CH2), 49.72 (2CH2), 49.88 (2CH2), 67.71 
(2CH2), 106.82 (CH), 107.17 (CH), 111.15 (CH), arC: [107.17 (2CH), 
111.15 (CH), 118.63 (CH), 119.49 (CH), 121.87 (CH), 127.93 (C), 
137.45 (C), 139.46 (C), 145.49 (C), 148.26 and 150.60 (C, d, JC-F= 
234.0 Hz), 152.10 (C), 154.55 (C), 162.78 (C)], 148.10 (quinolone 
CH), 162.78 (oxadiazole C-2), 167.20 (oxadiazole C-5), 176.67 
(C=O). EI MS m/z (%): 675.46 (100), 676.47 (50), 602.40 (36), 
618.35 [(M+1), 35]+, 646.39 (19). 
7-{4-[(5-[(2-(1H-Indol-3-yl)ethylamino)methyl]-2-
thioxo-1,3,4-oxadiazol-3(2H)-yl)methyl]piperazin-1-yl}-1-
ethyl-6-fluoro-4-oxo-1,4-dihydroquinoline-3-carboxylic 
acid (5b). Mp. 181-183 0C. FT-IR (υmax, cm-1): 3058 (aromatic 
CH), 1711 (C=O), 1664 (C=O), 1234 (C=S). 1H NMR (DMSO-d6, δ 
ppm): 1.35 (3H, s, CH3), 2.67 (4H, s, 2CH2), 2.89 (4H, s, 2CH2), 
2.27 (2H, s, CH2), 3.95 (2H, s, CH2), 4.53 (4H, s, 2CH2), 4.96 (2H, 
s, CH2), 7.05-7.18 (3H, m, arH), 7.57-7.60 (2H, m, arH), 7.95 
(1H, s, arH), 8.86 (2H, s, 2CH), 11.00 (2H, s, 2NH), 15.30 (1H, 
s, OH). 13C NMR (DMSO-d6, δ ppm): 14.73 (CH3), 45.20 (CH2), 
47.85 (CH2), 49.48 (2CH2), 49.89 (2CH2), 66.90 (2CH2), 70.80 
(CH2), 106.30 (CH), 107.51 (C), 111.00 (CH), arC: [111.44 (CH), 
111.67 (CH), 118.93 (CH), 119.64 (CH), 121.85 (CH), 122.10 (CH), 
128.03 (C), 137.49 (C), 139.10 (C), 140.87 (C), 145.77 and 147.80 
(C, d, JC-F= 203.0 Hz), 151.99 (C), 154.47 (C)], 148.79 (quinolone 
CH), 162.78 (oxadiazole C-5), 163.91 (oxadiazole C-2), 166.55 
(C=O), 176.52 (C=O). EI MS m/z (%): 651.38 (100), 663.40 
([M+K+H2O+1]
+, 56), 652.38 (40), 576.42 (31), 664.33 (25), 
695.37 (19). 
General Method for The Synthesis of Compounds 6a-c
Method 1: A mixture of compound 3 (10 mmol) and the 
corresponding iso(thio)cyanate (10 mmol) in dichloromethane 
was stirred at room temperature for 24 h. The solid precipitate 
was collected by fi ltration and recrystallized from ethanol to 
afford the desired compound.
Method 2: A mixture of compound 3 (10 mmol) and the 
corresponding iso(thio)cyanate (10 mmol) in dichloromethane 
was irradiated in monomod microwave reactor in closed 
vessel with the pressure control (Table 1). On cooling it to 
room temperature, a solid appeared. The crude product was 
recrystallized from acetone:diethyl ether (1:2, v/v) to give the 
desired product.
2-({[2-(1H-Indol-3-yl)ethyl ]amino}acety l )-N-
phenylhydrazinecarboxamide (6a). Mp. 255-256°C. FT-IR 
(υmax, cm-1): 3345 (5NH), 3044 (aromatic CH), 1770 and 1709 
(2C=O). 1H NMR (DMSO-d6, δ ppm): 3.01-3.04 (2H, m, CH2), 
3.58-3.68 (2H, m, CH2), 4.17 (2H, s, CH2), 7.03 (2H, d, J= 8.0 Hz, 
arH), 7.10-7.26 (1H, m, arH), 7.33-7.40 (4H, m, arH), 7.46-7.50 
(2H, m, arH), 7.59 (1H, d, J= 4.0 Hz, CH), 10.90 (5H, s, 5NH). 13C 
NMR (DMSO-d6, δ ppm): 23.72 (CH2), 43.61 (CH2), 50.08 (CH2), 
arC: [111.42 (C), 111.96 (CH), 118.57 (CH), 118.85 (CH), 121.52 
(CH), 123.43 (CH), 127.07 (2CH), 127.60 (C), 128.21 (2CH), 129.19 
(CH), 132.76 (C), 136.74 (C)], 155.62 and 169.87 (2C=O). EI MS 
m/z (%): 339.51 ([M+2]+, 100), 358.47 (84), 358.28 (78), 302.66 
(68), 308.98 (62), 359.41 (60), 342.58 (50), 361.41 (34), 378.55 
(31), 343.52 (30). 
2-({[2-(1H-Indol-3-yl)ethyl ]amino}acety l )-N-
phenylhydrazinecarbothioamide (6b). Mp. 148-149°C. FT-IR 
(υmax, cm-1): 3201 and 2989 (4NH), 1704 (C=O), 1210 (C=S).1H 
NMR (DMSO-d6, δ ppm): 3.11 (2H, t, J= 16.0 Hz, CH2), 4.04 (2H, 
t, J= 16.0 Hz, CH2), 4.37 (2H, s, CH2), 7.03-7.27 (2H, m, arH), 
7.30-7.32 (3H, m, arH), 7.37 (1H, s, arH), 7.46-7.51 (3H, m, 
arH), 7.66 (1H, d, J= 4.0 Hz, CH), 10.94 (5H, s, 5NH). 13C NMR 
(DMSO-d6, δ ppm): 22.80 (CH2), 47.87 (CH2), 53.37 (CH2), 111.08 
(C), 112.01 (CH), arC: [118.95 (3CH), 121.61 (2CH), 123.55 (2CH), 
127.61 (C), 129.07 (2CH), 134.39 (C), 136.74 (C)], 171.11 (C=O), 
181.88 (C=S). EI MS m/z (%): 368.29 (100), 369.36 (30). 
N-Benzyl-2-({[2-(1H-indol-3-yl)ethyl]amino}acetyl)
hydrazinecarbothioamide (6c). Mp. 148-149°C. FT-IR (υ max/
cm-1): 3374 and 3281 (5NH), 3061 (aromatic CH), 1732 (C=O), 
1232 (C=S).1H NMR (DMSO-d6, δ ppm): 3.09-3.06 (2H, m, CH2), 
4.00 (2H, t, J=8.0 Hz, CH2), 4.28 (2H, s, CH2), 4.79 (2H, d, J=4.0 
Hz, CH2), 6.98-7.09 (1H, m, arH), 7.23-7.29 (1H, m, arH), 7.32-
7.37 (6H, m, arH), 7.60 (1H, m, arH), 8.68 (1H, brs, CH), 10.05 
(2H, s, 2NH), 10.91 (3H, s, 3NH).13C NMR (DMSO-d6, δ ppm): 
22.88 (CH2), 44.75 (CH2), 47.00 (CH2), 52.82 (CH2), 111.10 (CH), 
127.97 (C), arC: [123.51 (CH), 127.19 (CH), 127.55 (CH), 127.78 
(CH), 127.83 (CH), 128.60 (2CH), 128.61 (2CH), 136.81 (C), 
139.90 (C), 152.17 (C)], 171.68 (C=O), 181.90 (C=S). EI MS m/z 
(%): 144.17 (100), 174.27 (40), 214.31 (31), 117.27 (30), 143.17 
(28), 359.41 (12), 420.48 ([M+K]+, 11). 
General Method for The Synthesis of Compounds 7a-c 
Method 1: The solution of the corresponding compound 
6a-c (10 mmol) in ethanol:water (1:1) was refl uxed in the 
presence 100 mL of 2 % NaOH for 6 h. Then the resulting 
solution was cooled to room temperature and acidifi ed to pH 4 
with 37% HCl. The precipitate formed was fi ltered off, washed 
with water, and recrystallized from ethyl acetate to afford the 
desired compound.
Method 2: The mixture of the corresponding compound 
6a-c (10 mmol) and 2 % NaOH (100 mL) was irradiated in 
monomod microwave reactor in closed vessel with the pressure 
control (Table 1). Upon acidifi cation of reaction content to pH 7 
with 37% HCl, a white solid appeared. This crude product was 
fi ltered off, washed with water and recrystallized from ethyl 
acetate to afford the desired product.
3-{[(2-(1H-Indol-3-yl)ethyl)amino]methyl}-4-phenyl-
1H-1,2,4-triazole-5(4H)-one (7a). Mp. 135-136°C.FT-IR υ max/
cm-1): 3397 and 3275 (2NH), 3057 (aromatic CH), 1683 (C=O). 
1H NMR (DMSO-d6, δ ppm): 2.99-3.02 (2H, m, CH2), 4.35 (4H, 
brs, 2CH2), 7.01-7.15 (5H, m, arH), 7.37 (2H, d, J=8.0 Hz, arH), 
7.55 (2H, d, J=8.0 Hz, arH), 9.24 (1H, s, CH), 10.91 (2H, s, 2NH), 
11.40 (1H, s, NH). 13C NMR (DMSO-d6, δ ppm): 51.41 (CH2), 66.71 
(2CH2), 107.02 (CH), arC: [107.27 (CH), 114.68 (CH), 118.73 (2CH), 
119.85 (CH), 122.33 (2CH), 129.22 (2CH),135.53 (C), 135.63 (C), 
140.07 (C), 152.96 (C)], 155.42 (triazole C-3) ,156.63 (triazole 
C-5). EI MS m/z (%): 468.34 (100), 446.38 (43), 469.40 (31), 
447.51 (17), 353.34 ([M+H2O+2]
+, 10). 
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3-{[(2-(1H-Indol-3-yl)ethyl)amino]methyl}-4-phenyl-
1H-1,2,4-triazole-5(4H)-thione (7b). Mp. 135-136°C. FT-IR 
(υmax/cm-1): 3161 (2NH), 3061 (aromatic CH), 1284 (C=S). 1H NMR 
(DMSO-d6, δ ppm): 3.07 (2H, t, J= 16.0 Hz, CH2), 4.53 (2H, s, 
CH2), 4.71-4.73 (2H, d, J=8.0 Hz, CH2), 7.22 (1H, brs, arH), 7.29-
7.30 (1H, m, arH), 7.31-7.37 (7H, m, arH), 7.66 (1H, d, J= 4.0 Hz, 
CH), 8.29 (1H, s, NH), 8.75 (1H, s, NH), 10.90 (1H, s, NH). 13C 
NMR (DMSO-d6, δ ppm): 46.43 (CH2), 50.29 (CH2), 52.84 (CH2), 
arC: [112.02 (CH), 115.07 (CH), 118.67 (CH), 118.94 (CH), 121.51 
(CH), 123.49 (CH), 123.72 (CH), 127.22 (C), 127.57 (2CH), 128.74 
(CH), 136.77 (C), 163.99 (C), 168.63 (C)], 171.51 (triazole C-3), 
181.79 (triazole C-5). EI MS m/z (%): 361.41 (100), 364.29 (33), 
372.30 ([M+Na]+, 31), 356.28 (20), 332.32 (18). 
3-{[(2-(1H-Indol-3-yl)ethyl)amino]methyl}-4-benzyl-
1H-1,2,4-triazole-5(4H)-thione (7c). Mp. 135-136°C. FT-IR 
(υ max/cm-1): 3296 and 3239 (3NH), 3061 (aromatic CH), 1587 
(C=N), 1223 (C=S). 1H NMR (DMSO-d6, δ ppm): 2.00 (8H, d, 
J=8.0 Hz, 4CH2), 7.17 (2H, d, J=8.0 Hz, arH), 7.33 (3H, t, J=8.0 Hz, 
arH), 7.59 (4H, d, J=8.0 Hz, arH), 9.83 (1H, s, CH), 10.34 (2H, 
s, 3NH). 13C NMR (DMSO-d6, δ ppm): 18.35 (CH2), 22.27 (CH2), 
23.68 (CH2), 25.51 (CH2), 128.48 (CH), arC: [118.26 (2C), 129.08 
(CH), 129.15 (CH), 129.25 (CH), 129.29 (CH), 129.40 (CH), 129.86 
(CH), 130.00 (CH), 130.45 (CH), 130.53 (CH), 139.53 (2C)], 153.21 
(triazole C-3), 176.82 (triazole C-5). EI MS m/z (%): 360.47 
(100), 368.42 (49), 361.54 (36), 381.50 (34), 370.42 (13). 
General Method for The Synthesis of Compounds 8a-f 
Method 1: To a solution of corresponding compound 7 (10 
mmol) in dimethyl formamide ciprofl oxacin (for 8a, 8c, 8e) 
or norfl oxacin (for 8b, 8c, 8f) (10 mmol) was added and the 
mixture was stirred at room temperature in the presence of 
formaldehyde (30 mmol) and InCl3 (1 mmol) for 24 h. The solid 
precipitate was collected by fi ltration, washed with water and 
recrystallized from dimethylsulfoxide:water (1:1) to give the 
desired compound.
Method 2: The mixture consisting of the corresponding 
compound 7 (10 mmol), ciprofl oxacin (for 8a, 8c, 8e) or 
norfl oxacin (for 8b, 8c, 8f) (10 mmol), formaldehyde (30 mmol) 
and InCl3 (1 mmol) was irradiated in monomod microwave 
reactor in closed vessel with the pressure control with 100 W 
maximum power for 7 min. The solid obtained was washed 
with water and recrystallized from ethyl acetate to give the 
desired compound. 
7-{ 4 - [(3-[(2-(1H-Indol-3-yl)ethylamino)methyl]-5-oxo-
4-phenyl-4,5-dihydro-1,2,4-triazol-1-yl)methyl]piperazin-
1-yl}-1-cyclopropyl-6-fl uoro-4-oxo-1,4-dihydroquinoline-
3-carboxylic acid (8a). Mp. 183-185°C. FT-IR (υmax, cm-1): 3269 
(NH), 3063 (aromatic CH), 1719 (C=O), 1664 (C=O), 1599 (C=N). 
1H NMR (DMSO-d6, δ ppm): 1.18 (2H, s, CH2), 1.31 (2H, s, CH2), 
2.09 (2H, s, CH2), 2.70 (2H, s, CH2), 2.73 (2H, s, CH2), 2.89 (2H, 
s, CH2), 3.71 (2H, s, CH2), 3.82 (2H, s, CH2), 4.58-4.62 (2H, m, 
CH2), 4.91 (2H, s, CH2), 6.97 (2H, s, arH), 7.25-7.29 (4H, m, 
arH), 7.48-7.62 (4H, m, arH), 7.89 (1H, s, arH), 8.66 (3H, d, 
J=4.0 Hz, 3CH), 9.34 (1H, s, NH), 10.60 (1H, s, NH), 15.21 (1H, s, 
OH).13C NMR (DMSO-d6, δ ppm): 8.02 (CH2), 43.96 (CH2), 48.39 
(CH2), 49.80 (CH2), 49.96 (CH2), 50.20 (CH2), 63.05 (CH2), 72.10 
(CH2), 75.17 (CH2), 82.41 (CH2), 119.89 (2CH), 120.12 (CH), arC: 
[120.22 (CH), 120.29 (CH), 120.37 (CH), 120.60 (CH), 120.90 
(CH), 123.26 (CH), 128.80 (CH), 128.83 (2CH), 128.88 (2CH), 
128.96 (C), 129.13 (C), 139.62 (C), 139.92 (2C), 140.85 (C), 152.86 
and 154.05 (C, d, JC-F= 119.0 Hz), 154.37 (2C)], 154.71 (triazole 
C-3), 155.43 (triazole C-5), 166.38 (C=O), 176.83(C=O). EI MS 
m/z (%): 685.56 (100), 685.81 (81), 684.31 (62), 675.52 (48), 
699.37 [(M+Na), 25]+, 717.51 [(M+K), 21]+, 676.71 [(M), 15]+. 
7-{4-[(3-[(2-(1H-Indol-3-yl)ethylamino)methyl]-5-oxo-
4-phenyl-4,5-dihydro-1,2,4-triazol-1-yl)methyl]piperazin-
1-yl}-1-ethyl-6-fluoro-4-oxo-1,4-dihydroquinoline-3-
carboxylic acid (8b). Mp.178-180°C. FT-IR (υmax, cm-1): 3266 
(NH), 3063 (aromatic CH), 1708 (C=O), 1663 (C=O), 1598 
(C=N).1H NMR (DMSO-d6, δ ppm): 1.41 (3H, d, J=4.0 Hz, CH3), 
2.73 (4H, s, 2CH2), 2.89 (6H, s, 3CH2), 3.75 (4H, s, 2CH2), 4.59 
(4H, s, 2CH2), 7.01-7.25 (3H, m, arH), 7.26-7.29 (4H, m, arH), 
7.50 (4H, s, arH), 7.89 (2H, s, CH), 8.94 (1H, s, NH), 10.50 (1H, 
s, NH), 15.35 (1H, s, OH). 13C NMR (DMSO-d6, δ ppm): 14.80 
(CH3), 36.24 (CH2), 44.02 (CH2), 61.31(CH2), 63.05 (CH2), 72.11 
(CH2), 79.96 (2CH2), 82.41 (2CH2), 107.59 (2CH), arC: [120.14 
(CH), 120.29 (CH), 120.37 (CH), 128.79 (2CH), 128.83 (3CH), 
128.96 (3CH), 137.63 (2C), 139.57 (2C), 139.73 (2C), 140.85 (2C), 
152.10 and 154.37 (C, d, JC-F= 227.0 Hz)], 154.60 (triazole C-3), 
155.42 (triazole C-5), 166.56 (C=O), 176.62 (C=O). EI MS m/z 
(%): 685.56 (100), 686.63 (48), 688.45 ([M+Na]+, 28), 683.49 
([M+H2O]
+, 17). 
7 - { 4 - [(3-[(2-(1H-Indol-3-yl)ethylamino)methyl]-4-
phenyl-5-thioxo-4,5-dihydro-1,2,4-triazol-1-yl)methyl]
piperazin-1-yl}-1-cyclopropyl-6-fluoro-4-oxo-1,4-
dihydroquinoline-3-carboxylic acid (8c). Mp. 188-189 °C, 
FT-IR (υmax, cm-1): 3262 (OH), 3198 (NH), 3128 (NH), 3053 
(aromatic CH), 1717 (C=O), 1663 (C=O), 1545 (C=N). 1H NMR 
(DMSO-d6, δ ppm): 1.16 (2H, d, J=8.0 Hz, CH2), 1.30 (2H, d, J=8.0 
Hz, CH2), 2.72 (2H, s, CH2), 2.88 (2H, s, CH2), 3.04 (2H, s, CH2), 
3.46 (2H, s, CH2), 4.62 (2H, s, CH2), 4.75 (2H, s, CH2), 5.16 (2H, 
s, CH2), 5.37 (4H, s, 2CH2), 7.23 (4H, d, J=8.0 Hz, arH), 7.48- 
7.58 (7H, m, arH), 8.62 (1H, s, CH), 8.64 (1H, s, CH), 8.89 (1H, 
s, CH), 9.27 (1H, s, NH), 9.38 (1H, s, NH), 15.20 (1H, s, OH). 13C 
NMR (DMSO-d6, δ ppm): 8.03 (CH2), 31.24 (CH2), 36.24 (CH2), 
36.28 (CH2), 49.93 (CH2), 50.11 (2CH2), 66.17 (2CH2), 68.77 
(2CH2), 106.91 (CH), 111.25 (CH), arC: [111.48 (CH), 117.71 and 
117.76 (CH, d, J=5.0 Hz), 118.39 (CH), 118.50 (C), 121.47 (CH), 
122.15 (CH), 125.55 (C), 128.44 and 128.83 (CH, d, J=39.0 Hz), 
129.11 (CH), 129.94 (2CH), 130.04 (CH), 130.12 (CH), 133.56 
(C), 139.59 (C), 140.29 (2C), 147.68 and 150.01 (C, d, JC-F= 233.0 
Hz), 162.77 (2C)], 148.36 (quinolone CH), 166.38 (triazole C-3), 
166.94 (triazole C-5), 171.57 (C=O), 176.77 (C=O). EI MS m/z 
(%): 512.20 (100), 693.74 ([M+1]+, 85), 631.85 (73), 378.72 (60), 
436.90 (34). 
7-{4-[(3-[(2-(1H-Indol-3-yl)ethylamino)methyl]-
4-phenyl-5-thioxo-4,5-dihydro-1,2,4-triazol-1-yl)
methyl]piperazin-1-yl}-1-ethyl-6-fluoro-4-oxo-1,4-
dihydroquinoline-3-carboxylic acid (8d). Mp. 180-181 °C.FT-IR 
(υmax, cm-1): 3262 (OH), 3198 (NH), 3128 (NH), 3053 (aromatic 
CH), 1717 (C=O), 1663 (C=O), 1545 (C=N).1H NMR (DMSO-d6, δ 
ppm): 1.39 (3H, t, J=8.0 Hz, CH3), 2.73 (2H, s, CH2), 2.88 (4H, s, 
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2CH2), 3.03 (4H, s, 2CH2), 3.34 (2H, s, CH2), 4.55 (4H, t, J=4.0 
Hz, 2CH2), 5.16 (2H, s, CH2), 6.93-7.87 (11H, m, arH), 7.89 (1H, 
s, CH), 7.95 (1H, s, CH), 8.48 (1H, s, NH), 8.93 (1H, s, NH), 
15.35 (1H, s, OH).13C NMR (DMSO-d6, δ ppm): 14.76 (CH3), 44.94 
(CH2), 49.52 (CH2), 50.03 (CH2), 50.15 (2CH2), 51.07 (2CH2), 
68.77 (2CH2), 107.52 (CH), arC: [111.48 (CH), 111.48 (CH), 111.71 
and 111.76 (CH, d, J=5.0 Hz), 118.49 (CH), 119.68 (CH), 122.27 
and 122.14 (CH, d, J=13.0 Hz), 124.06 (CH), 125.04 (CH), 125.73 
(CH), 126.42 (CH), 126.53 (CH), 133.55 (2C), 137.61 (2C), 140.29 
(2C), 145.91 (2C), 148.84 and 150.92 (C, d, JC-F= 208 Hz)], 147.67 
(quinolone CH), 152.05 (triazole C-3), 166.57 (triazole C-5), 
166.92 (C=O), 176.58 (C=O). EI MS m/z (%): 577.26 (100), 
430.25 (86), 412.38 (73), 681.20 ([M+1]+, 65), 612.45 (39). 
7-{4-[(3-[(2-(1H-Indol-3-yl)ethylamino)methyl]-4-
benzyl-5-thioxo-4,5-dihydro-1,2,4-triazol-1-yl)methyl]
piperazin-1-yl}-1-cyclopropyl-6-fluoro-4-oxo-1,4-
dihydroquinoline-3-carboxylic acid (8e). Mp.191-193°C. FT-IR 
(υmax, cm-1): 3260 (NH), 3070 (aromatic CH), 1718 (C=O), 1666 
(C=O). 1H NMR (DMSO-d6, δ ppm): 1.17 (2H, d, J=20.0 Hz, CH2), 
1.27-1.32 (2H, m, CH2), 2.75 (4H, s, 2CH2), 2.87 (4H, s, 2CH2), 
3.28 (2H, s, CH2), 4.29 (2H, s, CH2), 4.76 (2H, d, J=4.0 Hz, CH2), 
4.89 (2H, s, CH2), 4.98 (2H, s, CH2), 6.48 (1H, s, arH), 7.02 (1H, 
s, arH), 7.22-7.25 (6H, s, arH), 7.30 (3H, d, J=4.0 Hz, arH), 7.95 
(1H, s, CH), 8.63 (1H, s, CH), 8.66 (1H, s, CH), 8.98 (1H, s, NH), 
11.43 (1H, s, NH), 15.21 (1H, s, OH).13C NMR (DMSO-d6, δ ppm): 
8.02 (CH2), 22.62 (CH2), 31.24 (CH2), 36.24 (CH2), 44.73 (CH2), 
46.99 (CH2), 47.57 (CH2), 48.37 (CH2), 49.90 (CH2), 51.09 (CH2), 
52.87 (CH2), 106.82 (CH), 107.19 (CH), arC: [110.83 (CH), 111.28 
(CH), 127.18 (CH), 127.79 (CH), 127.82 (CH), 127.95 (CH), 128.48 
(C), 128.57 (CH), 128.79 (2CH), 128.91 (2CH), 134.21 (C), 136.77 
(C), 136.69 (C), 143.68 and 145.60 (C, d, JC-F= 192.0 Hz), 169.79 
(2C), 166.39 (2C)], 148.41 (quinolone CH), 171.65 (triazole C-3), 
176.80 (triazole C-5), 178.49 (C=O), 181.92 (C=O). EI MS m/z 
(%): 735.53 (100), 715.32 (97), 736.41 (93), 697.61 (82), 715.19 
(81), 719.40 (80), 731.45 (78), 706.09 ([M]+, 55), 707.60 ([M+1]+, 
44), 729.44 ([M+Na]+, 33), 724.48 ([M+H2O]
+, 31). 
7-{4-[(3-[(2-(1H-Indol-3-yl)ethylamino)methyl]-
4-benzyl-5-thioxo-4,5-dihydro-1,2,4-triazol-1-yl)
methyl]piperazin-1-yl}-1-ethyl-6-fluoro-4-oxo-1,4-
dihydroquinoline-3-carboxylic acid (8f). Mp. 189-190°C. F 
T-IR (υmax, cm-1): 3281 (NH), 3067 (aromatic CH), 1716 (C=O), 
1667 (C=O). 1H NMR (DMSO-d6, δ ppm): 1.36-1.44 (3H, m, CH3), 
2.51 (2H, s, CH2), 2.69 (2H, s, CH2), 2.73 (2H, s, CH2), 2.89 (2H, 
s, CH2), 4.30 (2H, s, CH2), 4.58 (2H, s, CH2), 4.75 (2H, d, J=8.0 
Hz, CH2), 4.89 (2H, s, CH2), 4.98 (4H, s, 2CH2), 7.18-7.28 (8H, 
m, arH), 7.30 (1H, d, J=4.0 Hz, arH), 7.89-7.95 (2H, m, arH), 
8.91 (1H, s, CH), 8.95 (1H, s, CH), 11.42 (2H, s, NH), 15.35 (1H, 
s, OH). 13C NMR (DMSO-d6, δ ppm): 14.72 (CH3), 46.98 (CH2), 
49.54 (CH2), 49.99 (CH2), 51.08 (CH2), 52.85 (2CH2), 79.95 
(2CH2), 80.07 (2CH2), 111.49 (CH), arC: [107.52 and 107.55 (C, 
d, J=3.0 Hz), 111.72 (CH), 118.90 (CH), 119.41 (CH), 119.66 and 
119.74 (C, d, J=8.0 Hz), 127.17 (CH), 127.44 (CH), 127.62 (CH), 
127.74 (CH), 127.78 (CH), 127.81 (CH), 127.95 (CH), 128.23 and 
128.48 (CH, d, J=25.0 Hz), 162.78 (2C), 148.80 and 150.87 (C, 
d, JC-F= 207.0 Hz), 171.65 (2C), 176.61 (2C)], 148.92 (quinolone 
CH), 176.61 (triazole C-3), 178.49 (triazole C-5), 181.92 (2C=O). 
EI MS m/z (%): 685.56 (100), 703.26 (74), 681.29 (73), 651.29 
(68), 663.34 (50), 604.14 (49), 695.35 ([M+1]+, 22). 
General Method for The Synthesis of Compounds 9a-c 
Method 1: A mixture of compound 6 (10 mmol) and ethyl 
bromoacetate (10 mmol) in absolute ethanol was refl uxed in 
the presence of dried sodium acetate (50 mmol) for 18 h. The 
reaction mixture was cooled to room temperature and the salt 
was separated by fi ltration. After the solvent was removed 
under reduced pressure, a solid appeared. This crude product 
was recrystallized from acetone-water (1:1) to afford the 
desired product.
Method 2: A mixture of compound 6 (10 mmol) and ethyl 
bromoacetate (10 mmol) and dried sodium acetate (50 mmol) 
was irradiated in monomod microwave reactor in closed vessel 
with pressure control (Table 1). The solid obtained was treated 
with 50 mL of water, the precipitate was collected by fi ltration 
and recrystallized from acetone-water (1:1) to afford the 
desired product.
2-{[2-(1H-Indol-3-yl)ethyl]amino}-N’-(5-oxo-3-
phenyloxazolidin-2-ylidene) acetohydrazide (9a). Mp.152-
153°C. FT-IR (υmax, cm-1): 3211 (NH), 3092 (aromatic CH), 1595 
(C=N), 1693 (C=O), 1720 (C=O), 1241 (C-O). 1H NMR (DMSO-d6, 
δ ppm): 2.10 (2H, s, CH2), 3.03 (2H, s, CH2), 3.67 (2H, s, CH2), 
4.11 (2H, s, CH2), 6.50-6.72 (2H, m, arH), 7.10-7.28 (3H, m, 
arH), 7.35-7.45 (4H, m, arH), 8.10 (1H, s, CH), 9.20 (1H, s, NH), 
10.10 (2H, s, 2NH). 13C NMR (DMSO-d6, δ ppm): 23.70 (CH2), 
43.61 (CH2), 50.08 (2CH2), 111.42 (C), 111.95 (CH), arC: [114.37 
(CH), 116.15 (CH), 118.56 (CH), 118.85 (CH), 118.96 (CH), 121.51 
(CH), 122.33 (CH), 123.42 (CH), 127.06 (CH), 136.73 (C), 140.14 
(C), 155.62 (C), 156.52 (C)], 169.87 (2C=O). EI MS m/z (%): 
378.12 (100), 563.78 (83), 496.21 (75), 414.52 ([M+Na]+, 66), 
217.52 (36). 
2-{[2-(1H-Indol-3-yl)ethyl]amino}-N’-(3-phenyl-5-
oxothiazolidin-2-ylidene)acetohydrazide (9b). Mp.134-136°C. 
FT-IR (υmax, cm-1): 3309 (NH), 3109 (aromatic CH), 1727 (C=O). 
1H NMR (DMSO-d6, δ ppm): 1.28 (2H, s, CH2), 1.45 (2H, s, CH2), 
4.01 (2H, s, CH2), 3.53 (2H, s, CH2+H2O), 7.30-7.42 (3H, m, 
arH), 7.43-7.49 (3H, m, arH), 7.51 (3H, s, arH), 10.77 (1H, s, 
CH), 10.89 (3H, s, 3NH).13C NMR (DMSO-d6, δ ppm): 18.71 (CH2), 
24.86 (CH2), 32.55 (CH2), 39.20 (CH2), 111.99 (CH), arC: [118.63 
(CH), 123.54 (CH), 124.67 (CH), 128.44 (CH), 128.81 (CH), 129.05 
(CH), 129.20 (CH), 129.26 (2CH), 140.11 (C), 141.76 (C), 143.82 
(C), 150.77 (C), 161.41 (C)], 172.21 (2C=O). EI MS m/z (%): 427.36 
(100), 447.44 (70), 429.49 ([M+Na]+, 67), 425.29 (51), 44 1.37 
(48), 433.43 (45), 434.43(28). 
2-{[2-(1H-Indol-3-yl)ethyl]amino}-N’-(3-benzyl-5-
oxothiazolidin-2-ylidene) acetohydrazide (9c). Mp.132-134°C. 
FT-IR (υmax, cm-1): 3289 (NH), 3032 (aromatic CH), 1709 (C=O), 
1599 (C=N). 1H NMR (DMSO-d6, δ ppm): 3.10 (2H, s, CH2), 4.28 
(2H, s, CH2), 4.81 (2H, d, J=12.0 Hz, CH2), 4.91 (2H, s, CH2), 5.14 
(2H, s, CH2), 6.97- 7.08 (1H, m, arH), 7.22-7.27 (1H, m, arH), 
7.29-7.59 (7H, m, arH), 7.61 (1H, s, CH), 9.52 (2H, s, 2NH), 
10.91 (1H, s, NH).13C NMR (DMSO-d6, δ ppm): 25.22 (CH2), 39.76 
(CH2), 41.76 (CH2), 45.78 (CH2), 52.60 (CH2), 110.95 (C), 111.97 
(CH), arC: [121.56 (CH), 123.50 (CH), 127.77 (CH), 127.95 (CH), 
128.04 (CH), 128.09 (CH), 128.70 (CH), 128.73 (CH), 128.82 
(CH), 136.35 (C), 136.80 (C), 150.11 (C), 171.69 (C), 172.23 (C)], 
181.89 (2C=O). EI MS m/z (%): 360.47 (100), 447.44 (95), 327.31 
(65), 323.31 (58), 283.20 (55), 381.43 (51), 355.28 (38). 
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General Method for the Synthesis of Compounds 10a-c
Method 1: A mixture of the corresponding compound 6 (10 
mmol) and 2-bromo-1-(4-chlorophenyl)ethanone (10 mmol) 
in absolute ethanol was refl uxed in the presence of dried 
sodium acetate (50 mmol) for 17-20 h. The reaction mixture 
was cooled to room temperature and the salt was separated 
by fi ltration. After the solvent was removed under reduced 
pressure, an oily product obtained. This was extracted with 15 
mL of ethyl acetate three times. The organic layer was dried on 
Na2SO4 and evaporated under reduced pressure. The obtained 
crude product was recrystallized from acetone: petroleum 
ether (1:1).
Method 2: A mixture of the corresponding compound 6 
(10 mmol), 2-bromo-1-(4-chlorophenyl)ethanone (10 mmol) 
and dried sodium acetate (50 mmol) in absolute ethanol was 
irradiated in monomod microwave reactor in closed vessel with 
pressure control (Table 1). The solid obtained was treated with 
50 mL of water, the precipitate was collected by fi ltration and 
recrystallized from acetone-petroleum ether (1:1) to afford the 
desired product.
2-{[2-(1 H-Indol-3-yl )e thy l ]amino}- N’-[5-(4-
c h l o r o p h e n y l ) - 3 - p h e n y l - o x a z o l - 2 ( 3 H ) - y l i d e n e ] 
acetohydrazide (10a). Mp.141-142°C. (Method 2), FT-IR (υmax, 
cm-1): 3294 (NH), 3092 (aromatic CH), 1595 (C=N), 1698 (C=O), 
1241 (C-O). 1H NMR (DMSO-d6, δ ppm): 2.15 (2H, s, CH2), 3.10 
(2H, s, CH2), 5.45 (2H, s, CH2), 6.95 (3H, s, arH), 7.25 (5H, s, 
arH), 7.49 (5H, s, arH), 7.97 (2H, s, 2CH), 8.76 (2H, s, 2NH)., 
9.80 (1H, s, NH). 13C NMR (DMSO-d6, δ ppm): 23.70 (CH2), 48.25 
(CH2), 66.82 (CH2), 114.34 (2CH), arC: [118.94 (2CH), 122.31 
(2CH), 127.06 (2CH), 129.07 (2CH), 129.52 (2CH), 130.16 (3CH), 
140.14 (2C), 156.49 (2C), 160.31 (2C), 161.4 (2C)], 169.18 (C=O). 
EI MS m/z (%): 312.25 (100), 547.36 (78), 296.34 (65), 486.23 
([M+1]+, 51). 
2-{[2-(1H-Indol-3-yl)ethyl]amino}-N’-[3-phenyl-5-(4-
chlorophenyl)thiazol-2(3H)-ylidene] acetohydrazide (10b). 
Mp.137-138°C. FT-IR (υmax, cm-1): 3319 (NH), 3049 (aromatic 
CH), 1712 (C=O). 1H NMR (DMSO-d6, δ ppm): 2.15 (2H, s, CH2), 
2.70 (2H, s, CH2), 5.46 (2H, s, CH2), 6.57 (1H, s, arH), 7.15-7.35 
(11H, m, arH), 7.65 (1H, s, arH), 10.93 (2H, s, 2CH), 11.10 (1H, s, 
NH), 11.70 (1H, s, NH), 12.66 (1H, s, NH). 13C NMR (DMSO-d6, δ 
ppm): 31.15 (CH2), 66.83 (2CH2), 102.26 (CH), 116.77 (CH), arC: 
[127.88 (CH), 128.85 (CH), 128.79 (CH), 128.92 (CH), 129.14 
(CH), 129.52 (2CH), 130.12 (2CH), 130.17 (2CH), 131.42 (2CH), 
138.34 (2C), 159.63 (2C), 160.75 (2C), 170.33 (2C)], 192.46 (C=O). 
EI MS m/z (%): 427.36 (100), 447.44 (70), 452.49 ([M+Na]+, 
67), 425.29 (51), 44 1.37 (48), 433.43 (45), 434.43(28). 
2-{[2-(1H-Indol-3-yl)ethyl]amino}-N’-[3-benzyl-5-(4-
chlorophenyl)thiazol-2(3H)-ylidene] acetohydrazide (10c). 
Mp.148-150°C. FT-IR (υmax, cm-1): 3217 (NH), 3086 (aromatic 
CH), 1590 (C=N). 1H NMR (DMSO-d6, δ ppm): 4.37 (2H, d, J=4.0 
Hz, CH2), 4.91 (2H, s, CH2), 5.46 (4H, s, 2CH2), 7.19-7.59 (8H, 
m, arH), 7.64 (5H, d, J=8.0 Hz, arH), 10.92 (1H, s, CH), 12.21 
(1H, s, CH), 12.37 (3H, s, 3NH). 13C NMR (DMSO-d6, δ ppm): 
44.73 (CH2), 52.85 (CH2), 66.83 (2CH2), 110.95 (C), 111.97 (CH), 
118.62 (CH), arC: [118.89 (CH), 121.55 (CH), 127.96 (CH), 128.53 
(CH), 128.77 (CH), 128.80 (CH), 128.91 (CH), 129.03 (2CH), 
129.52 (2CH), 130.17 (2CH), 136.72 (2C), 140.85 (C), 150.36 (C), 
171.68 (C), 181.88 (2C)], 191.45 (C=O). EI MS m/z (%): 612.54 
(100), 554.78 ([M+K]+, 65), 502.57 (51), 378.56 (45). 
Antibacterial activity assessment
The test microorganisms were obtained from the 
Hifzissihha Institute of Refi k Saydam (Ankara, Turkey) and 
were as follows: Escherichia coli (E. coli) ATCC35218, Yersinia 
pseudotuberculosis (Y. pseudotuberculosis) ATCC911, Pseudomonas 
aeruginosa (P. aeruginosa) ATCC43288, Enterococcus faecalis 
(E. faecalis) ATCC29212, Staphylococcus aureus (S. aureus) 
ATCC25923, Bacillus cereus (B. cereus) 709 Roma, Mycobacterium 
smegmatis (M. smegmatis) ATCC607. All the newly synthesized 
compounds were weighed and dissolved in dimethyl sulfoxide 
to prepare extract stock solution of 20.000 microgram/milliliter 
(μg/mL).
The antibacterial effects of the substances were tested 
quantitatively in respective broth media by using double 
microdilution and the minimal inhibition concentration 
(MIC) values (μg/mL) were determined. The antibacterial 
and antifungal assays were performed in Mueller-Hinton 
broth (MH) (Difco, Detroit, MI) at pH.7.3 and buffered Yeast 
Nitrogen Base (Difco, Detroit, MI) at pH 7.0, respectively. The 
micro dilution test plates were incubated for 18-24 h at 35 
°C. Brain Heart Infusion broth (BHI) (Difco, Detriot, MI) was 
used for M. smegmatis, and incubated for 48-72 h at 35 °C [41]. 
Ampicillin (10 μg) and fl uconazole (5μg) were used as standard 
antibacterial and antifungal drugs, respectively. Dimethyl 
sulfoxide with dilution of 1:10 was used as solvent control. The 
results obtained were presented in table 3.
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